Yayınlar & Eserler

Yayın Ağı

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Inhibition of PI3K-AKT-mTOR pathway and modulation of histone deacetylase enzymes reduce the growth of acute myeloid leukemia cells

Şansaçar M., Sağır H., GENCER AKÇOK E. B.
Medical Oncology , cilt.41, sa.1, 2024 (SCI-Expanded) identifier identifier

Determination of promising inhibitors for N-SH2 domain of SHP2 tyrosine phosphatase: an in silico study

Gencer Akçok E. B., GÜNER H., AKÇOK İ.
Molecular Diversity , 2024 (SCI-Expanded) Creative Commons License identifier identifier

Histone Deacetylase Inhibition and Autophagy Modulation Induces a Synergistic Antiproliferative Effect and Cell Death in Cholangiocarcinoma Cells

Yenigül M., GENCER AKÇOK E. B.
ACS Omega , cilt.8, sa.24, ss.21755-21768, 2023 (SCI-Expanded) identifier identifier

Ethacrynic acid and cinnamic acid combination exhibits selective anticancer effects on K562 chronic myeloid leukemia cells

Yenigul M., AKÇOK İ., GENCER AKÇOK E. B.
MOLECULAR BIOLOGY REPORTS , cilt.49, sa.8, ss.7521-7530, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Investigation of the Antitumor Effect of Targeting PI3K-AKT-mTOR Pathway and Histone Deacetylase Enzymes on Acute Myeloid Leukemia Cells

ŞANSAÇAR M., Sagir H., GENCER AKÇOK E. B.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.21, 2021 (SCI-Expanded) identifier

Dissection of the BCR-ABL signaling network using highly specific monobody inhibitors to the SHP2 SH2 domains

Sha F., Gencer E. B., Georgeon S., Koide A., Yasui N., Koide S., et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , cilt.110, sa.37, ss.14924-14929, 2013 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

Mechanisms of resistance to BCR-ABL and other kinase inhibitors

Lamontanara A. J., Gencer E. B., Kuzyk O., Hantschel O.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS , cilt.1834, sa.7, ss.1449-1459, 2013 (SCI-Expanded) identifier identifier identifier

Mechanisms responsible for nilotinib resistance in human chronic myeloid leukemia cells and reversal of resistance

Camgoz A., Gencer E. B., Ural A. U., Baran Y.
LEUKEMIA & LYMPHOMA , cilt.54, sa.6, ss.1279-1287, 2013 (SCI-Expanded) Creative Commons License identifier identifier identifier

A novel mechanism of dasatinib-induced apoptosis in chronic myeloid leukemia; ceramide synthase and ceramide clearance genes

Gencer E. B., URAL A. U., AVCU F., Baran Y.
ANNALS OF HEMATOLOGY , cilt.90, sa.11, ss.1265-1275, 2011 (SCI-Expanded) Creative Commons License identifier identifier identifier

Roles of ceramide synthase and ceramide clearence genes in nilotinib-induced cell death in chronic myeloidleukemia cells

Camgoz A., Gencer E. B., Ural A. U., AVCU F., Baran Y.
LEUKEMIA & LYMPHOMA , cilt.52, sa.8, ss.1574-1584, 2011 (SCI-Expanded) Creative Commons License identifier identifier identifier

Diğer Dergilerde Yayınlanan Makaleler

Measurement of Autophagic Activity in Cancer Cells with Flow Cytometric Analysis Using Cyto-ID Staining.

Şansaçar M., Gencer Akçok E. B.
Methods in molecular biology (Clifton, N.J.) , 2024 (Scopus) identifier

The therapeutic potential of targeting HDAC6 with Tubastatin A in TFK-1 and EGI-1 cholangiocarcinoma cells

YENİGÜL M., GENCER AKCOK E. B.
Cumhuriyet Science Journal , cilt.42, sa.4, ss.775-780, 2021 (Hakemli Dergi) Sürdürülebilir Kalkınma identifier

Metrikler

Yayın

14

Atıf (WoS)

137

H-İndeks (WoS)

5

Atıf (Scopus)

210

H-İndeks (Scopus)

6

Proje

4

Tez Danışmanlığı

2

Açık Erişim

5
BM Sürdürülebilir Kalkınma Amaçları